Antibody Drug Development News

A team of bioengineers in David Baker’s group have built microscopic assemblies, known as synthetic nucleocapsids, to protect genetic materials they are packaging.

When geneticist Barbara McClintock discovered “jumping gene” 60 years ago, biologists were skeptical about the discovery and even laughed at McClintock’s theory.

Targeted immune checkpoint protein PD1 (programmed cell death protein 1) and its ligand PD-L1 have been approved in the treatment of several cancers.

T lymphocytes play a central role in protecting human beings against intracellular pathogens or tumor antigens that requires T-cell mediated immune responses.